Mutations in progranulin explain atypical phenotypes with variants in MAPT

Stuart M. Pickering-Brown, Matt Baker, Jenny Gass, Bradley F. Boeve, Clement T. Loy, William S. Brooks, Ian R.A. Mackenzie, Ralph N. Martins, John B.J. Kwok, Glenda M. Halliday, Jillian Kril, Peter R. Schofield, David M.A. Mann, Mike Hutton

Research output: Contribution to journalArticlepeer-review

85 Scopus citations


Mutations in presenilin-1 (PSEN1) cause autosomal dominant Alzheimer's disease and mutations in MAPT cause the familial tauopathy Frontotemporal dementia linked to chromosome 17 (FTDP-17). However, there have been reports of mutations in PSEN1 and MAPT associated with cases of FTD with ubiquitin-positive tau-negative inclusion pathology. Here, we demonstrate that the MAPT variants are almost certainly rare benign polymorphisms as all of these cases harbour mutations in Progranulin (PGRN). Mutations in PGRN were recently shown to cause ubiquitin-positive FTDP-17.

Original languageEnglish (US)
Pages (from-to)3124-3126
Number of pages3
Issue number11
StatePublished - Nov 2006


  • FTLD-U
  • Frontotemporal dementia
  • MAPT
  • Progranulin

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Mutations in progranulin explain atypical phenotypes with variants in MAPT'. Together they form a unique fingerprint.

Cite this